Health
PET/CT insights predict immunotherapy response in patients with advanced lung cancer – Health Imaging
Checkpoint inhibitors target the PD-L1/PD1 signaling pathway and are commonly used to treat those with NSCLC. While this therapy can be highly effective, it only works for nearly 50% of patients.
In order to avoid treating those who likely wont respond,…
Continue Reading
-
Noosa News5 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News6 hours agoMotorcyclist dies in crash with truck
-
Noosa News20 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General20 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
